Early discharge from the emergency department resulted in more than 10,000 Medicare patients dying, annually. Researchers determined that low-volume hospitals actually had higher rates of early death.
A substantial number of Medicare patients die within a week of discharge from the emergency department (ED) despite having no evidence of a life-limiting illness, according to new research published in BMJ.
As the numbers of patients visiting the ED increases, hospitals and providers need to decide whether to admit or discharge a patient and errors can result in an avoidable harm to patients who could benefit from monitoring or treatment as inpatients.
Researchers at Harvard and Brigham and Women’s Hospital analyzed a nationally representative 20% sample of Medicare fee-for-service beneficiaries of generally healthy people living in the community. They excluded data on patients in nursing facilities, age 90 years or older, receiving palliative or hospice care, or with a diagnosis of a life-limiting illness.
The researchers determined that more than 10,000 Medicare patients die every year soon after discharge, despite being relatively young and having no previous life-limiting illness. The leading causes of death for these patients were atherosclerotic heart disease (13.6%), myocardial infarction (10.3%), and chronic obstructive pulmonary disease (9.6%).
Based on the data, hospitals with lower admissions rates—those in the lowest fifth of rates of inpatient admission from the ED—actually had the highest rates of early death. The rate of death (0.27%) was 3.4 times higher than hospitals in the highest fifth. This was despite the fact that the hospitals had lower patient volumes and served an overall healthier patient population.
“Hospitals with low admission rates and low patient volumes, and patients with high risk diagnoses at discharge, could represent targets for clinical research and quality improvement efforts,” the researchers wrote.
According to the authors, their findings have implications for efforts to reduce unnecessary ED admissions.
“Unless extreme care is taken with selection of patients, these well intentioned efforts could put patients at risk,” they wrote. “Novel metrics to track patient safety and diagnostic error … are urgently needed to aid policy makers in evaluating how changes in the broader healthcare system impact patient outcomes.”
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen